Nothing Special   »   [go: up one dir, main page]

KR100670440B1 - The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components - Google Patents

The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components Download PDF

Info

Publication number
KR100670440B1
KR100670440B1 KR1020060017043A KR20060017043A KR100670440B1 KR 100670440 B1 KR100670440 B1 KR 100670440B1 KR 1020060017043 A KR1020060017043 A KR 1020060017043A KR 20060017043 A KR20060017043 A KR 20060017043A KR 100670440 B1 KR100670440 B1 KR 100670440B1
Authority
KR
South Korea
Prior art keywords
adenosine
licorice extract
oil
soluble licorice
composition
Prior art date
Application number
KR1020060017043A
Other languages
Korean (ko)
Inventor
한충섭
김종천
박진희
Original Assignee
주식회사 하이넷포쉬에화장품
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 하이넷포쉬에화장품 filed Critical 주식회사 하이넷포쉬에화장품
Priority to KR1020060017043A priority Critical patent/KR100670440B1/en
Application granted granted Critical
Publication of KR100670440B1 publication Critical patent/KR100670440B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A cosmetic composition is provided to show excellent transdermal absorptivity of adenosine and oil soluble licorice extract, and be able to stably preserve the composition for a long period of time without losing the activity of the adenosine and licorice extract by containing liposomed adenosine and soluble licorice extract. The cosmetic composition stabilizing adenosine and oil soluble licorice extract through the liposome technique comprises 0.01-4.0 wt. of adenosine, 0.01-5 wt.% of the oil soluble licorice extract, 1.0-10.0 wt.% of lecithin, 0.1-2.0 wt.% of ceramide, 0.1-5.0 wt.% of tocopheryl acetate, 0.01-1.0 wt.% of citric acid, and 0.1-40.0 wt.% of at least one emulsification stabilizing supplement selected from the group consisting of propyleneglycol, butyleneglycol, glycerine, xylitol and natural polymer compounds.

Description

아데노신 및 유용성 감초 추출물의 리포좀 기술을 이용한 안정화 기술 및 이를 함유하는 화장료 조성물과 그의 제조방법{The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components.}The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components.}

제1도는 아데노신을 함유한 화장료 조성물의 농도에 따른 세포 증식 효과를 나타낸다.Figure 1 shows the cell proliferation effect according to the concentration of the cosmetic composition containing adenosine.

제2도는 아데노신을 함유한 화장료 조성물의 농도에 따른 콜라겐 합성 증진 효과를 나타낸다.Figure 2 shows the collagen synthesis promoting effect according to the concentration of the cosmetic composition containing adenosine.

제3도는 유용성 감초 추출물을 함유한 화장료 조성물의 농도에 따른 미백효과를 나타낸다.Figure 3 shows the whitening effect of the concentration of the cosmetic composition containing the oil-soluble licorice extract.

본 발명은 생리활성물질의 리포좀 기법을 이용한 안정화 기술 및 이를 함유하는 화장료 조성물과 그의 제조 방법에 관한 것이다.The present invention relates to a stabilization technique using a liposome technique of a bioactive substance, and a cosmetic composition containing the same and a method for producing the same.

최근 피부노화 지연 및 미백 등을 목적으로 한 특정의 생리활성 물질을 함유 하는 기능성 화장료에 대한 관심이 높아지고 또 많은 연구가 행해지고 있다. 본 발명도 이러한 기능성 화장료에 관한 것으로서 피부노화를 억제하는 기능을 갖는 아데노신 및 피부에 미백작용을 하는 유용성 감초 추출물을 함유하는 화장료 조성물이다. 이러한 아데노신 또는 유용성 감초 추출물의 기능을 화장료에 응용하기 위하여 아데노신 또는 유용성 감초 추출물을 화장료에 첨가한 화장료가 제안된바 있다. 그러나 종래의 화장료들은 화장료 조성물에 아데노신 또는 유용성 감초 추출물을 단순히 첨가하여 제조한 단순유화 타입 또는 젤 타입의 제품들로서 화장료 내에 충분한 양을 배합하기가 어렵고 배합이 되더라도 피부내의 침투가 쉽지 않다. 또한 화장료 보존 시 침전되어 적용 등에 한계가 있는 결점을 갖고 있다. 그 이유로는 아데노신의 경우 낮은 온도의 정제수에는 거의 녹지 않고 고온, 즉 70도 이상에서만 녹기 때문에 화장료에 적용하여도 장기적인 안정도를 관찰해보면 분리현상이나 침전현상이 발생되어 적정량의 적용이 어려운 상황이다.In recent years, interest in functional cosmetics containing specific bioactive substances for the purpose of delaying skin aging and whitening has been increasing and many studies have been conducted. The present invention also relates to such a functional cosmetic composition comprising adenosine having a function of inhibiting skin aging and a cosmetic composition containing an oil-soluble licorice extract for whitening the skin. In order to apply the function of such adenosine or oil-soluble licorice extract to cosmetics, cosmetics have been proposed in which adenosine or oil-soluble licorice extract is added to cosmetics. However, conventional cosmetics are simple emulsified type or gel type products prepared by simply adding adenosine or oil-soluble licorice extract to the cosmetic composition, and it is difficult to formulate a sufficient amount in the cosmetic and is difficult to penetrate into the skin even when formulated. In addition, the preservation of cosmetics has a drawback that is limited to the application of precipitation. The reason for this is that adenosine is hardly soluble in low temperature purified water, but melts only at high temperature, that is, above 70 ° C, so that even if it is applied to cosmetics, it is difficult to apply an appropriate amount due to separation or sedimentation.

한편, 리포좀 화장료의 경우에도 아데노신의 용해도 특성 때문에 침전이 발생하므로 리포좀의 장점인 피부침투력을 기대하기 어려운 상황이므로 처방 시에 용매를 선택해야 하는 문제점이 있었다.On the other hand, even in the case of liposome cosmetics because precipitation occurs because of the solubility characteristics of adenosine, it is difficult to expect skin penetration, which is an advantage of liposomes, so there was a problem in selecting a solvent at the time of prescription.

이러한 상황 하에서 본 발명자들은 상기한 문제점을 갖지 않고 피부 침투력이 우수하며 장기간 활성의 손실 없이 안정하게 보존할 수 있는 아테노신 및 유용성 감초 추출물 함유 화장료의 조성물을 제공하고자 예의 연구한 결과 아데노신 및 유용성 감초 추출물을 리포좀 화하여 이것을 화장료에 첨가함으로써 상기 목적을 달성할 수 있음을 발견하고 본 발명을 완성하기에 이르렀다.Under such circumstances, the inventors of the present invention have conducted a thorough study to provide a composition of adenosine and oil-soluble licorice extract containing cosmetics that have excellent skin penetration and excellent stability without loss of long-term activity without the above-mentioned problems. The present invention has been accomplished by discovering that the above object can be achieved by liposome-forming and adding it to a cosmetic.

즉, 본 발명의 목적은 총 조성물 중량의 1.0-10.0%의 레시틴, 조성물 총 중량의 0.1-2.0%의 세라마이드, 조성물 총 중량의 0.01-4.0%의 아데노신, 조성물 총 중량의 0.01-5.0%의 유용성 감초 추출물과 조성물 총 중량의 0.1-1.0%의 씨트릭애씨드로 이루어진 리포좀을 함유함을 특징으로 하는 아데노신 및 유용성 감초 추출물 함유화장료 조성물을 제공하는 것이다.That is, an object of the present invention is 1.0-10.0% lecithin of the total composition weight, 0.1-2.0% ceramide of the total weight of the composition, 0.01-4.0% adenosine of the total weight of the composition, 0.01-5.0% of the total weight of the composition To provide adenosine and oil-soluble licorice extract-containing cosmetic composition, characterized in that it contains liposome consisting of 0.1-1.0% of the citric acid of the total weight of the licorice extract and composition.

본 발명의 또 다른 목적은 정제수, 레시틴, 세라마이드, 토코페릴아세테이트, 아데노신, 유용성 감초 추출물과 씨트릭애씨드를 함유하는 혼합물을 고압균질기(High Pressure Homogenizer)에 통과시켜 아데노신 및 유용성 감초 추출물함유 리포좀이 고르게 분산된 화장료 조성물의 제조방법을 제공하는 것이다.Still another object of the present invention is to pass a mixture containing purified water, lecithin, ceramide, tocopheryl acetate, adenosine, oil-soluble licorice extract and citric acid through a High Pressure Homogenizer to adenosine and oil-soluble licorice extract-containing liposomes. It is to provide a method for producing a cosmetic composition evenly dispersed.

이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명에 따라 제공하는 화장료 조성물은 리포좀 화된 아데노신 및 유용성 감초 추출물을 함유하기 때문에 아데노신 및 유용성 감초 추출물의 경피 흡수성이 매우 뛰어나며 아데노신 및 유용성 감초 추출물의 활성이 손실되는 일 없이 장기간 안정하게 보존할 수 있다.Since the cosmetic composition provided according to the present invention contains liposome-ized adenosine and oil-soluble licorice extract, it has excellent transdermal absorption of adenosine and oil-soluble licorice extract, and can be stably preserved for a long time without losing the activity of adenosine and oil-soluble licorice extract. .

본 발명에서 리포좀 화시킬 아데노신과 접촉하여 아데노신을 함유하는 리포좀을 형성하기 위한 물질로는 레시틴이 사용되며, 조성물 총 중량에 대하여 1.0%-10.0%의 양으로 사용된다.In the present invention, a material for forming liposomes containing adenosine in contact with adenosine to be liposomed is used with lecithin, and is used in an amount of 1.0% -10.0% based on the total weight of the composition.

본 발명에서 사용되는 세라마이드는 조성물 총 중량에 대하여 0.1-2.0%의 양으로 사용된다.The ceramides used in the present invention are used in amounts of 0.1-2.0% based on the total weight of the composition.

본 발명에서 사용되는 토코페릴아세테이트는 조성물 총 중량에 대하여 0.1-5.0%의 양으로 사용된다.Tocopheryl acetate used in the present invention is used in an amount of 0.1-5.0% based on the total weight of the composition.

본 발명에서 아데노신의 용해도를 높이기 위해 씨트릭애씨드가 사용되며 조성물 총 중량에 대하여 0.01-1.0%의 양으로 사용된다.Citric acid is used in the present invention to increase the solubility of adenosine and is used in an amount of 0.01-1.0% based on the total weight of the composition.

본 발명의 화장료 조성물은 아데노신 및 유용성 감초 추출물을 안정화시키기 위해 유화안정 보조제를 함유할 수 있으며, 예를 들면 프로필렌글리콜, 부틸렌글리콜, 글리세린, 자이리톨, 천연 고분자 화합물 등의 폴리머를 조성물 총 중량에 대하여 0.1-40.0%의 양으로 사용할 수 있다.The cosmetic composition of the present invention may contain an emulsifying stabilizer to stabilize adenosine and oil-soluble licorice extract, and for example, polymers such as propylene glycol, butylene glycol, glycerin, xyitol, natural polymer compounds, etc., with respect to the total weight of the composition. It can be used in an amount of 0.1-40.0%.

본 발명의 방법에 따르면, 먼저 정제수, 씨트릭애씨드를 70-80도에서 호모믹서로 교반하여 식힌 후 온도를 50-60도정도 유지하여 균질의 수용액을 만들고 수용액으로 아데노신을 50-60도에서 용해시켜 아데노신용액을 만든다. 레시틴과 세라마이드를 40도에서 프로필렌글리콜로 용해시키고 유용성 감초 추출물과 토코페릴아세테이트를 첨가하여 균질 화된 레시틴용액을 만든 후 레시틴용액을 먼저 준비한 수용액에 서서히 첨가하여 유화 액을 얻는다. 얻어진 유화 액을 고압균질기에 통과시켜 아데노신 및 유용성 감초 추출물함유 리포좀을 고르게 분산시킨 유화액을 얻는다.According to the method of the present invention, first, purified water and citric acid were stirred with a homomixer at 70-80 degrees, cooled, and then maintained at a temperature of about 50-60 degrees to form a homogeneous aqueous solution, and the adenosine was dissolved at 50-60 degrees with an aqueous solution. To make an adenosine solution. Lecithin and ceramide are dissolved in propylene glycol at 40 ° C, oil-soluble licorice extract and tocopheryl acetate are added to make a homogenized lecithin solution, and the lecithin solution is slowly added to the prepared aqueous solution to obtain an emulsion. The obtained emulsion is passed through a high pressure homogenizer to obtain an emulsion in which adenosine and oil-soluble licorice extract-containing liposomes are evenly dispersed.

이상과 같은 본 발명의 방법에 의하여 종래 화장품에서 사용되어지던 아데노신 및 유용성 감초 추출물을 보다 안정하고 활성의 손실 없이 화장료에 배합하고 또한 피부에 적용 시에 침투성을 향상시킴으로써 아데노신이 갖는 콜라겐 생성기능과 유용성 감초 추출물이 갖는 피부미백 기능을 충분히 발휘할 수 있는 유화 타입 의 화장료를 제공하는 것이 가능하여졌다.The adenosine and oil-soluble licorice extracts that have been used in conventional cosmetics by the method of the present invention as described above are more stable and blended into cosmetics without loss of activity, and also improve the permeability when applied to the skin collagen production function and utility of adenosine It has become possible to provide an emulsion type cosmetic that can sufficiently exhibit the skin whitening function of licorice extract.

이하 실시 예를 통하여 본 발명을 보다 상세히 설명하지만 본 발명이 이들 실시 예에만 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

표 1. 실시 예 1 및 비교 예 1Table 1. Example 1 and Comparative Example 1

Figure 112006501543154-pat00014
Figure 112006501543154-pat00014

제조방법Manufacturing method

실시 예 1 : 원료물질 1,2,3,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 수상에 50-60도에서 용해시키고 규질 화하여 아데노신 용액이라 칭한다. 원료물질 7 및 8을 40도에서 원료물질 9에 용해시키고 균질 화한 후 원료물질 10 및 11을 첨가하고 균질 화하여 레시틴 용액이라 칭한다. 상기 아데노신용액과 레시틴용액을 30-40도에서 서서히 혼합하여 균질 화시킨 후 고압균질기(High Pressure Homogenizer)를 통과하여 아데노신 및 유용성 감초 추출물 함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 1 Raw materials 1,2,3,12 and 13 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved and silicified at 50-60 degrees in the water phase and is called adenosine solution. The raw materials 7 and 8 are dissolved and homogenized in the raw material 9 at 40 degrees, and then the raw materials 10 and 11 are added and homogenized to be called a lecithin solution. The adenosine solution and the lecithin solution were slowly mixed and homogenized at 30-40 degrees, and then passed through a high pressure homogenizer to obtain an emulsion of adenosine and an oil-containing licorice extract containing a uniformly dispersed emulsion. -Maturate for 7 days.

비교 예 1 : 원료물질 1,4,12 및 13을 70-80도에서 혼합하고 균질 화하여 아데노신용액이라 칭한다. 아데노신용액에 70-80도에서 원료물질 5를 용해시키고 균질화하여 원료물질 6과 11을 첨가한 후 균질 화하여2-7일간 숙성시킨다.Comparative Example 1: The raw materials 1, 4, 12 and 13 are mixed and homogenized at 70-80 degrees to be called adenosine solution. Dissolve and homogenize raw material 5 in adenosine solution at 70-80 degrees, add raw materials 6 and 11, homogenize and mature for 2-7 days.

표 2. 실시 예 2 및 비교 예 2Table 2. Example 2 and Comparative Example 2

Figure 112006501543154-pat00015
Figure 112006501543154-pat00015

제조방법Manufacturing method

실시 예 2 : 원료물질 1,2,3,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 수상에 50-60도에서 용해시키고 규질 화하여 아데노신용액이라 칭한다. 원료물질 7 및 8을 40도에서 원료물질 9에 용해시키고 균질 화한 후 원료물질 10 및 11을 첨가하고 균질 화하여 레시틴 용액이라 칭한다. 상기 아데노신용액과 레시틴용액을 30-40도에서 서서히 혼합하여 균질 화시킨 후 고압균 질기(High Pressure Homogenizer)를 통과하여 아데노신 및 유용성 감초 추출물 함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 2 Raw materials 1,2,3,12 and 13 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in a water phase at 50-60 degrees and silicified to be called adenosine solution. The raw materials 7 and 8 are dissolved and homogenized in the raw material 9 at 40 degrees, and then the raw materials 10 and 11 are added and homogenized to be called a lecithin solution. The adenosine solution and the lecithin solution are gradually mixed and homogenized at 30-40 degrees, and then passed through a high pressure homogenizer to obtain an emulsion of adenosine and an oil-soluble licorice extract containing a uniformly dispersed emulsion. -Maturate for 7 days.

비교 예 2 : 원료물질 1,4,12 및 13을 70-80도에서 혼합하고 균질 화하여 아데노신용액이라 칭한다. 아데노신용액에 70-80도에서 원료물질 5를 용해시키고 균질 화하여 원료물질 6과 11을 첨가한 후 균질 화하여 2-7일간 숙성시킨다.Comparative Example 2: The raw materials 1, 4, 12 and 13 are mixed and homogenized at 70-80 degrees to be called adenosine solution. Dissolve and homogenize raw material 5 in adenosine solution at 70-80 degrees, add raw materials 6 and 11, homogenize and mature for 2-7 days.

표 3. 실시 예 3 및 비교 예 3Table 3. Example 3 and Comparative Example 3

Figure 112006501543154-pat00016
Figure 112006501543154-pat00016

제조방법Manufacturing method

실시 예 3 : 통상의 단순 유화방법에 따라 원료물질 1,7 및 8을 70-80도에서 혼합하고 원료물질 6을 첨가하여 균질화한 후 원료물질 4 및 5를 첨가하여 잘 혼합한 후 30-35도에서 나머지 원료물질인 3을 혼합하고 균질 화하여 2-7일간 숙성시킨다.Example 3: According to a conventional simple emulsification method, the raw materials 1, 7 and 8 were mixed at 70-80 degrees, homogenized by adding the raw material 6, and then mixed well by adding the raw materials 4 and 5, and then 30-35. In the figure, the remaining raw material 3 is mixed and homogenized and aged for 2-7 days.

비교 예 3 : 통상의 단순 유화방법에 따라 원료물질 1,2,7 및 8을 70-80도에서 혼합하고 원료물질 6을 첨가하여 균질 화한 후 원료물질 4 및 5를 잘 혼합하여 균질 화한 뒤 2-7일간 숙성시킨다.Comparative Example 3 After mixing the raw materials 1,2,7 and 8 at 70-80 degrees according to the conventional simple emulsification method and homogenizing by adding the raw material 6, homogenizing by mixing the raw materials 4 and 5 well 2 -Maturate for 7 days.

표 4. 실시 예 4 및 비교 예 4Table 4. Example 4 and Comparative Example 4

Figure 112006501543154-pat00017
Figure 112006501543154-pat00017

제조방법Manufacturing method

실시 예 4 : 원료물질 1,2,3,10 및 11을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 수상에 50-60도에서 용해시키고 규질 화하여 아데노신용액이라 칭한다. 원료물질 5 및 6을 40도에서 원료물질 7에 용해시키고 균질 화한 후 원료물질 8 및 9를 첨가하고 균질 화하여 레시틴 용액이라 칭한다. 상기 아데노신용액과 레시틴용액을 30-40도에서 서서히 혼합하여 균질 화시킨 후 고압균질기(High Pressure Homogenizer)를 통과하여 아데노신 및 유용성 감초 추출물 함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 4 Raw materials 1,2,3,10 and 11 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in a water phase at 50-60 degrees and silicified to be called adenosine solution. The raw materials 5 and 6 are dissolved and homogenized in the raw material 7 at 40 degrees, and then the raw materials 8 and 9 are added and homogenized to be called a lecithin solution. The adenosine solution and the lecithin solution were slowly mixed and homogenized at 30-40 degrees, and then passed through a high pressure homogenizer to obtain an emulsion of adenosine and an oil-containing licorice extract containing a uniformly dispersed emulsion. -Maturate for 7 days.

비교 예 4 : 원료물질 1,3,10 및 11을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 수상에 70-80도에서 용해시키고 규질 화하여 아데노신 용액이라 칭한다. 원료물질 5 및 6을 40도에서 원료물질 7에 용해시키고 균질 화한 후 원료물질 8 및 9를 첨가하고 균질 화하여 레시틴 용액이라 칭한다. 상기 아데노신용액과 레시틴용액을 30-40도에서 서서히 혼합하여 균질 화시킨 후 고압균질기(High Pressure Homogenizer)를 통과하여 아데노신 및 유용성 감초 추출물 함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Comparative Example 4: The raw materials 1, 3, 10 and 11 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in an aqueous phase at 70-80 degrees and silicified to be called an adenosine solution. The raw materials 5 and 6 are dissolved and homogenized in the raw material 7 at 40 degrees, and then the raw materials 8 and 9 are added and homogenized to be called a lecithin solution. The adenosine solution and the lecithin solution were slowly mixed and homogenized at 30-40 degrees, and then passed through a high pressure homogenizer to obtain an emulsion of adenosine and an oil-containing licorice extract containing a uniformly dispersed emulsion. -Maturate for 7 days.

[원심분리안정성시험][Centrifuge Stability Test]

상기의 실시 예 및 비교 예에 따라 제조된 제품들의 원심분리 안정성을 알아보기 위하여 제품을 각 500g씩 제조하여 적량씩 취하여 4000 RPM에서 10분, 8000 RPM에서 10분 및 12000 RPM에서 10분간 원심 분리하여 얻어진 결과를 표에 나타내었다.In order to determine the centrifugation stability of the products manufactured according to the above examples and comparative examples, 500g of each product was prepared and taken in an appropriate amount, followed by centrifugation at 10 minutes at 4000 RPM, 10 minutes at 8000 RPM, and 10 minutes at 12000 RPM. The results obtained are shown in the table.

표 5. 원심분리안정성 시험결과Table 5. Centrifuge Stability Test Results

Figure 112006501543154-pat00018
Figure 112006501543154-pat00018

상기 표의 원심분리안정성 시험결과에서 알 수 있는 바와 같이, 리포좀 기법을 이용하여 아데노신을 안정화시킨 화장료 조성물을 함유한 실시 예 1,2 및 3은 일반유화 기법으로 아데노신을 함유한 비교 예 1,2 및 3에 비하여 원심분리 안정성에 문제가 없는 것으로 확인되었다.As can be seen from the results of the centrifugation stability test of the table, Examples 1, 2, and 3 containing the cosmetic composition stabilized adenosine using the liposome technique are Comparative Examples 1, 2, and 3 containing adenosine by the general emulsification technique. It was confirmed that there is no problem in the centrifugation stability compared to 3.

또한, 씨트릭애씨드 수용액을 아데노신의 용매로 사용한 실시 예 4는 수용액을 아데노신 용매로 사용한 비교 예 4에 비하여 원심분리 안전성에 문제가 없는 것으로 확인되었다.In addition, Example 4 using the aqueous citric acid solution as the solvent of adenosine was confirmed that there is no problem in the centrifugation safety compared to Comparative Example 4 using the aqueous solution as the adenosine solvent.

상기 실시 예에서 제조된 원료를 사용하여 아래 처방 예와 같은 방법으로 제조하였다.Using the raw material prepared in the above Example was prepared in the same manner as in the formulation example below.

처방 예 1.Prescription Example 1.

아데노신함유 리포좀을 함유한 화장료 중 화장수(스킨로션)의 처방 예는 다 음과 같다. 여기에서 아데노신및유용성감초추출물함유 리포좀은 실시 예 1의 것이다.The following is a prescription example of a lotion (skin lotion) among cosmetics containing adenosine-containing liposomes. Herein, adenosine and oil-soluble licorice extract-containing liposomes are those of Example 1.

표 6. 본 발명에 따른 화장수(스킨로션)의 처방 예Table 6. Examples of prescription of lotion (skin lotion) according to the present invention

Figure 112006501543154-pat00006
Figure 112006501543154-pat00006

제조방법Manufacturing method

제형 예 1: 원료물질 11에 원료물질 2,3,4,8을 순서대로 투입하여 교반하여 용해시킨 후 원료물질 5를 60℃정도 가열하여 용해시킨 후 원료물질 10을 투입 교반하여 원료물질 11에 투입한다. 마지막으로 원료물질 1,6,7,9를 투입하여 충분히 교반한 뒤 고압균질기를 통과시킨 후 숙성시킨다.Formulation Example 1: Raw material 2,3,4,8 was added to raw material 11 in order, and then dissolved by stirring. Then, raw material 5 was heated to 60 ° C. to dissolve, and then raw material 10 was added and stirred to raw material 11. Input. Finally, the raw materials 1,6,7,9 are added and sufficiently stirred, and then aged through a high pressure homogenizer.

비교제형 예 1: 원료물질 11에 원료물질 2,3,4,8을 순서대로 투입하여 교반하여 용해시킨 후 원료물질 5를 60℃정도 가열하여 용해시킨 후 원료물질 10을 투입 교반하여 원료물질 11에 투입한다. 마지막으로 원료물질 6,7,9를 투입하여 충분히 교반한 뒤 고압균질기를 통과시킨 후 숙성시킨다.Comparative Example 1: Raw material 2,3,4,8 was added to raw material 11 in order, followed by stirring to dissolve it. Then, raw material 5 was heated and dissolved at about 60 ° C., and then raw material 10 was added and stirred to prepare raw material 11 Put it in. Finally, the raw materials 6, 7, and 9 are added and sufficiently stirred, and then aged through a high pressure homogenizer.

처방 예 2.Prescription Example 2.

아데노신및유용성감초추출물함유 리포좀을 함유한 화장료 중 영양로션의 처방 예는 다음과 같다. 여기에서 아데노신및유용성감초추출물함유 리포좀은 실시 예 1의 것이다.Prescription examples of nutritional lotions in cosmetics containing adenosine and oil-soluble licorice extracts are as follows. Herein, adenosine and oil-soluble licorice extract-containing liposomes are those of Example 1.

표 7. 본 발명에 따른 영양로션의 처방 예Table 7. Prescription examples of nutrition lotion according to the present invention

Figure 112006501543154-pat00007
Figure 112006501543154-pat00007

제조방법Manufacturing method

제형 예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시 킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 2: The raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Scream Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

비교제형 예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 2: The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

처방 예 3Prescription Example 3

아데노신및유용성감초추출물함유 리포좀을 함유한 화장료 중 영양크림의 처방 예는 다음과 같다. 여기에서 아데노신및유용성감초추출물함유 리포좀은 실시 예 1의 것이다.Prescription examples of nutritional creams in cosmetics containing liposomes containing adenosine and oil-soluble licorice extract are as follows. Herein, adenosine and oil-soluble licorice extract-containing liposomes are those of Example 1.

표 8. 본 발명에 따른 영양크림의 처방 예Table 8. Prescription example of nutrition cream according to the present invention

Figure 112006501543154-pat00008
Figure 112006501543154-pat00008

제조방법Manufacturing method

제형 예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 3: Raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Let's do it. Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

비교제형 예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 3 The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

처방 예 4.Prescription Example 4.

아데노신및유용성감초추출물함유 리포좀을 함유한 화장료 중 맛사지 크림의 처방 예는 다음과 같다. 여기에서 아데노신및유용성감초추출물함유 리포좀은 실시 예 1의 것이다.A prescription example of a massage cream in a cosmetic containing adenosine and a liposome containing a useful licorice extract is as follows. Herein, adenosine and oil-soluble licorice extract-containing liposomes are those of Example 1.

표 9. 본 발명에 따른 맛사지 크림의 처방 예Table 9. Prescription example of massage cream according to the present invention

Figure 112006501543154-pat00009
Figure 112006501543154-pat00009

제조방법Manufacturing method

제형 예 4 : 원료물질 8,9,10,11,13,16을 혼합 교반하면서 80-85도 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 원료물질 2,3,4,5,6,7,12를 80-85도 사이로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50도까지 냉각한 뒤 원료물질 14를 투입하고 45도까지 냉각한 뒤 원료물질 15를 투입하고 35도까지 냉각되면 원료물질 1을 투입한다. 25도까지 냉각한 뒤 숙성시킨다.Formulation Example 4: The raw materials 8,9,10,11,13,16 are heated to 80-85 degrees with mixed agitation, put into the manufacturing unit, and then the emulsifier is activated. 7,12 is heated to between 80-85 degrees and then emulsified. After emulsification, cool down to 50 degrees while stirring using a stirrer, add raw material 14, cool to 45 degrees, add raw material 15, and cool raw material 1 to 35 degrees. After cooling to 25 degrees, it is aged.

비교제형 예 4 : 원료물질 8,9,10,11,13,16을 혼합교반하면서 80-85도 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 원료물질 2,3,4,5,6,7,12를 80-85도 사이로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50도까지 냉각한 뒤 원료물질 14를 투입하고 45도까지 냉각한 뒤 원료물질 15를 투입하고 25도까지 냉각한 뒤 숙성시킨다.Comparative Formulation Example 4: The raw materials 8,9,10,11,13,16 were mixed and stirred to be heated to 80-85 ° C and introduced into the manufacturing unit, followed by the operation of an emulsifier. Heat 7,7,12 to 80-85 ° C and add to emulsify. After emulsification, cool to 50 degrees while stirring using a stirrer, add raw material 14, cool to 45 degrees, add raw material 15, cool to 25 degrees, and mature.

처방 예 5.Prescription Example 5.

아데노신및유용성감초추출물함유 리포좀을 함유한 화장료 중 영양 에센스의 처방 예는 다음과 같다. 여기에서 아데노신및유용성감초추출물함유 리포좀은 실시 예 1의 것이다.Prescription examples of nutritional essences in cosmetics containing adenosine and liposomes containing a useful licorice extract are as follows. Herein, adenosine and oil-soluble licorice extract-containing liposomes are those of Example 1.

표 10. 본 발명에 따른 영양 에센스의 처방 예Table 10. Prescription examples of nutritional essences according to the present invention

Figure 112006501543154-pat00010
Figure 112006501543154-pat00010

제조방법Manufacturing method

제형 예 5 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 5: The raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Let's do it. Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

비교제형 예 5 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 5: The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Then, the raw materials 10, 11, 12, 13 are added and dispersed to stabilize and mature.

Claims (4)

아데노신 및 유용성 감초 추출물을 리포좀 기법을 이용하여 안정화시킨 화장료 조성물.Cosmetic composition wherein adenosine and oil-soluble licorice extract are stabilized using liposome technique. 레시틴, 세라마이드, 토코페릴아세테이트, 아데노신, 유용성 감초 추출물, 씨트릭애씨드 및 유화안정보조제의 리포좀을 함유하는 아데노신 및 유용성 감초 추출물 함유 화장료 조성물로서,A cosmetic composition containing adenosine and an oil-soluble licorice extract containing liposomes of lecithin, ceramide, tocopheryl acetate, adenosine, oil-soluble licorice extract, citric acid and emulsifying eye preparation, 상기한 아데노신은 조성물 총 중량에 대해 0.01-4.0%의 양으로 함유되며,Adenosine described above is contained in an amount of 0.01-4.0% based on the total weight of the composition, 상기한 유용성 감초 추출물은 조성물 총 중량에 대해 0.01-5.0%의 양으로 함유되며,The oil-soluble licorice extract described above is contained in an amount of 0.01-5.0% based on the total weight of the composition, 상기한 레시틴은 조성물 총 중량에 대해 1.0-10.0%의 양으로 함유되며,Said lecithin is contained in an amount of 1.0-10.0% based on the total weight of the composition, 상기한 세라마이드는 조성물 총 중량에 대해 0.1-2.0%의 양으로 함유되며,Said ceramide is contained in an amount of 0.1-2.0% based on the total weight of the composition, 상기한 토코페릴아세테이트는 조성물 총 중량에 대해 0.1-5.0%의 양으로 함유되며,Tocopheryl acetate as described above is contained in an amount of 0.1-5.0% based on the total weight of the composition, 상기한 씨트릭애씨드는 조성물 총 중량에 대해 0.01-1.0%의 양으로 함유되며,The citric acid is contained in an amount of 0.01-1.0% based on the total weight of the composition, 상기한 유화안정보조제로서는 프로필렌글리콜, 부틸렌글리콜, 글리세린, 자이리톨 또는 천연고분자화합물로부터 선택된 1종 또는 2종 이상의 혼합물로서, 조성물 총 중량에 대해 0.1-40.0%의 양으로 함유됨을 특징으로 하는 아데노신 및 유 용성 감초 추출물 함유 화장료 조성물.The above emulsifying stability aids include adenosine, characterized in that it is contained in an amount of 0.1-40.0% based on the total weight of the composition as one or two or more mixtures selected from propylene glycol, butylene glycol, glycerin, gyritol or natural polymer compounds. Cosmetic composition containing a soluble licorice extract. 정제수, 레시틴, 세라마이드, 토코페릴아세테이트, 아데노신, 유용성 감초 추출물 및 씨트릭애씨드를 함유하는 혼합물을 고압균질기 (High Pressure Homogenizer)에 통과시켜 아데노신 및 유용성 감초 추출물함유 리포좀이 고르게 분산된 아데노신 및 유용성 감초 추출물함유 리포좀을 함유하는 화장료 조성물의 제조방법.Mixtures containing purified water, lecithin, ceramide, tocopheryl acetate, adenosine, oil-soluble licorice extract and citric acid are passed through a High Pressure Homogenizer to provide evenly dispersed adenosine and oil-soluble licosome containing adenosine and oil-soluble licorice extract A method for producing a cosmetic composition containing an extract-containing liposome. 제 1항에 있어서, 상기 화장료가 화장수(스킨로션), 영양로션, 영양크림, 맛사지크림 또는 영양에센스로 제형화됨을 특징으로 하는 화장료 조성물.The cosmetic composition of claim 1, wherein the cosmetic is formulated as a lotion (skin lotion), nutrition lotion, nutrition cream, massage cream or nutrition essence.
KR1020060017043A 2006-02-22 2006-02-22 The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components KR100670440B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060017043A KR100670440B1 (en) 2006-02-22 2006-02-22 The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060017043A KR100670440B1 (en) 2006-02-22 2006-02-22 The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components

Publications (1)

Publication Number Publication Date
KR100670440B1 true KR100670440B1 (en) 2007-01-16

Family

ID=38014027

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060017043A KR100670440B1 (en) 2006-02-22 2006-02-22 The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components

Country Status (1)

Country Link
KR (1) KR100670440B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101355216B1 (en) * 2012-11-19 2014-01-28 홍소영 A facial mask sheet comprising a composition comprising liposomes for accelerating percutaneous absorptionn
WO2017119560A1 (en) * 2016-01-07 2017-07-13 (주)바이오제닉스 Adenosine nonaqueous solubilization polyol solution and method for producing same
US9814670B2 (en) 2014-12-04 2017-11-14 Mary Kay Inc. Cosmetic compositions
KR102112104B1 (en) 2018-12-17 2020-05-18 가톨릭대학교 산학협력단 Method for manufacturing liposome containing extract of aronia having improved formulation stability
KR20210153435A (en) * 2020-06-10 2021-12-17 주식회사 넥스텍인터내셔널 Stabilizing method of adenosine and cosmetic composition containing the stabilized adenosine
US12097279B2 (en) 2017-09-18 2024-09-24 Mary Kay Inc. Cosmetic compositions and methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930021190A (en) * 1992-04-06 1993-11-22 최근선 Skin cosmetic composition
KR20040027829A (en) * 2004-03-11 2004-04-01 더미스킨(주) Nano liposome composition for herbs
KR20060022572A (en) * 2004-09-07 2006-03-10 주식회사 엘지생활건강 Cosmetic powder, its preparing method and make-up cosmetic composition comprising the same
KR20060061879A (en) * 2004-12-02 2006-06-08 한국콜마 주식회사 Cosmetic composition comprising nano size liposome and oil in water type emulsion and manufacturing method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930021190A (en) * 1992-04-06 1993-11-22 최근선 Skin cosmetic composition
KR20040027829A (en) * 2004-03-11 2004-04-01 더미스킨(주) Nano liposome composition for herbs
KR20060022572A (en) * 2004-09-07 2006-03-10 주식회사 엘지생활건강 Cosmetic powder, its preparing method and make-up cosmetic composition comprising the same
KR20060061879A (en) * 2004-12-02 2006-06-08 한국콜마 주식회사 Cosmetic composition comprising nano size liposome and oil in water type emulsion and manufacturing method thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101355216B1 (en) * 2012-11-19 2014-01-28 홍소영 A facial mask sheet comprising a composition comprising liposomes for accelerating percutaneous absorptionn
US9814670B2 (en) 2014-12-04 2017-11-14 Mary Kay Inc. Cosmetic compositions
US10272028B2 (en) 2014-12-04 2019-04-30 Mary Kay Inc. Cosmetic Compostions
US10881699B2 (en) 2014-12-04 2021-01-05 Mary Kay Inc. Cosmetic compositions
US11446218B2 (en) 2014-12-04 2022-09-20 Mary Kay Inc. Cosmetic compositions
US12036296B2 (en) 2014-12-04 2024-07-16 Mary Kay Inc. Cosmetic compositions
WO2017119560A1 (en) * 2016-01-07 2017-07-13 (주)바이오제닉스 Adenosine nonaqueous solubilization polyol solution and method for producing same
US12097279B2 (en) 2017-09-18 2024-09-24 Mary Kay Inc. Cosmetic compositions and methods
KR102112104B1 (en) 2018-12-17 2020-05-18 가톨릭대학교 산학협력단 Method for manufacturing liposome containing extract of aronia having improved formulation stability
KR20210153435A (en) * 2020-06-10 2021-12-17 주식회사 넥스텍인터내셔널 Stabilizing method of adenosine and cosmetic composition containing the stabilized adenosine
KR102415086B1 (en) 2020-06-10 2022-06-30 주식회사 넥스텍인터내셔널 Stabilizing method of adenosine and cosmetic composition containing the stabilized adenosine

Similar Documents

Publication Publication Date Title
CN110215416B (en) Camellia oil oleogel emulsion and preparation method thereof
KR102309619B1 (en) Method for manufacturing hair treatment agent for improvement damaged hair
CN111643376B (en) Nanoemulsion composition and application thereof
KR100670440B1 (en) The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components
JP4963958B2 (en) Stable concentrated and diluted oil-in-water emulsions, processes for their preparation, and formulation processes using these emulsions
JP2009161523A (en) External preparation for skin and production method thereof
CN113260422B (en) Ceramide dispersion composition
KR100638170B1 (en) Composition of oil phase having gemini type surfactant for stabilizing oil-soluble licorice extract and promoting its transepidermal absorption in whitening cosmetics and it's manufacturing method thereof
KR100737101B1 (en) The stability technology of using the technology of the liposome including adenosine which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components
JPH03293024A (en) Water-in-oil type emulsion with lecithin dispersed in water phase
JPH08283303A (en) Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic
CN109414390B (en) External preparation for skin
WO2014050709A1 (en) Cosmetic and glycyrrhetinic acid derivative-containing emulsification composition
WO2011099422A1 (en) Emulsion and cosmetic containing same
JPS61204109A (en) Emulsion-type composition for external use
KR100779819B1 (en) The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components.
KR20090040517A (en) The components of cosmetics with the liposome including botanical extract which is effective for anti-acne and the method of manufacturing the components
JPS594432A (en) Emulsion composition
JP5641665B2 (en) External preparation for skin and method for producing the same
WO2011108167A1 (en) Powdered composition, cosmetic material, and method for producing powdered composition
KR100522311B1 (en) The stability technology of using the technology of nano spherical particles including perfluorodecalin which is effective for anti-wrinkle and the components of cosmetics including the nano spherical particles and the method of manufacturing the components.
KR20190090703A (en) The Manufacturing process of emulsion containing Caviar and Composition Thereof
KR20200049150A (en) Oil-in-water type cosmetic composition with a low viscosity comprising a high content of oil
JP2007169174A (en) O/w type emulsified composition
KR101281820B1 (en) Cosmetic composition in which sheen and softness of oil and setting property of hydrophilic polymer coexists, and the preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130110

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140110

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150109

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160108

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170110

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180103

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20190110

Year of fee payment: 13